Last data update: Dec 02, 2024. (Total: 48272 publications since 2009)
Records 1-8 (of 8 Records) |
Query Trace: Heller D[original query] |
---|
Case 16-2024: A 20-year-old man with a pustular rash
Daskalakis DC , Heller HM , Shenoy ES , Hsu K . N Engl J Med 2024 390 (20) 1906-1912 |
Hepatitis C Guidance 2019 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Ghany MG , Marks KM , Morgan TR , Wyles DL , Aronsohn AI , Bhattacharya D , Broder T , Falade-Nwulia OO , Feld JJ , Gordon SC , Heller T , Jhaveri RR , Jonas MM , Kiser JJ , Linas BP , Lo Re V , Peters MG , Reddy KR , Reynolds A , Scott JD , Searson G , Spradling P , Terrault NA , Trooskin SB , Verna EC , Wong JB , Woolley AE , Workowski KA . Hepatology 2019 71 (2) 686-721 The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) initiated the hepatitis C guidance project (hereafter HCV guidance) in 2013. The AASLD-IDSA HCV guidance website (www.HCVGuidelines.org) disseminates up-to-date, peer-reviewed, unbiased, evidence-based recommendations to aid clinicians making decisions regarding the testing, management, and treatment of hepatitis C virus (HCV) infection. Utilizing a web-based system enables timely and nimble distribution of the HCV guidance, which is periodically updated in near real time as necessitated by emerging research data, recommendations from public health agencies, the availability of new therapeutic agents, or other significant developments affecting the rapidly evolving hepatitis C arena. |
Travel history is important! A case of Trypanosoma cruzi identified by placental examination
Heller DS , Romagano MP , Alzate-Duque L , Rubenstein S , Williams S , Madubuko A , Algarrahi K , Ritter JM , Faye-Petersen O . Pediatr Dev Pathol 2018 22 (2) 1093526618789298 A recent twin placenta revealed an unexpected diagnosis of Trypanosoma cruzi (T.cruzi). In | retrospect, the mother was recalled to be Argentinean and to have intermittently resided there. | A dichorionic-diamniotic twin pregnancy with preterm premature rupture of membranes | delivered at 24 4/7 weeks. Twin A had had ascites, pleural effusion, and intrauterine growth | restriction (IUGR). Twin B had mild ventriculomegaly. Both twins expired within hours of | birth. | Placenta A showed acute chorioamnionitis , funisitis and erythroblastosis. Placenta B showed | acute chorioamnionitis, necrotizing villitis, and numerous villous amastigotes within pseudocysts | in necrotic foci(fig 1). Immunohistochemical and PCR assays for T.cruzi were positive. | At autopsy, both twins showed extensive extramedullary hematopoiesis, erythroblastosis, and | rare T. cruzi organisms. |
Prevalence of Amyotrophic Lateral Sclerosis - United States, 2014.
Mehta P , Kaye W , Raymond J , Wu R , Larson T , Punjani R , Heller D , Cohen J , Peters T , Muravov O , Horton K . MMWR Morb Mortal Wkly Rep 2018 67 (7) 216-218 Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a progressive and fatal neuromuscular disease; the majority of ALS patients die within 2-5 years of receiving a diagnosis (1). Familial ALS, a hereditary form of the disease, accounts for 5%-10% of cases, whereas the remaining sporadic cases have no clearly defined etiology (1). ALS affects persons of all races and ethnicities; however, whites, males, non-Hispanics, persons aged >60 years, and those with a family history of ALS are more likely to develop the disease (1-3). No cure for ALS has yet been identified, and the lack of proven and effective therapeutic interventions is an ongoing challenge. Current treatments available do not cure ALS but have been shown to slow disease progression. Until recently, only one drug (riluzole) was approved to treat ALS; however, in 2017, the Food and Drug Administration approved a second drug, edaravone (4). |
Placental massive perivillous fibrinoid deposition associated with coxsackievirus A16-report of a case, and review of the literature
Heller DS , Tellier R , Pabbaraju K , Wong S , Faye-Petersen OM , Muehlenbachs A , Goldsmith C , Denison A , Zaki SR . Pediatr Dev Pathol 2016 19 (5) 421-423 Massive placental perivillous fibrinoid deposition in the placenta is thought to be an immune-related condition associated with poor perinatal outcomes, including growth restriction and intrauterine fetal demise, with a high risk of recurrence. Rare cases have been associated with Coxsackievirus infection. We present such a case and review the literature. |
How can the health system retain women in HIV treatment for a lifetime? A discrete choice experiment in Ethiopia and Mozambique
Kruk ME , Riley PL , Palma AM , Adhikari S , Ahoua L , Arnaldo C , Belo DF , Brusamento S , Cumba LI , Dziuban EJ , El-Sadr WM , Gutema Y , Habtamu Z , Heller T , Kidanu A , Langa J , Mahagaja E , McCarthy CF , Melaku Z , Shodell D , Tsiouris F , Young PR , Rabkin M . PLoS One 2016 11 (8) e0160764 INTRODUCTION: Option B+, an approach that involves provision of antiretroviral therapy (ART) to all HIV-infected pregnant women for life, is the preferred strategy for prevention of mother to child transmission of HIV. Lifelong retention in care is essential to its success. We conducted a discrete choice experiment in Ethiopia and Mozambique to identify health system characteristics preferred by HIV-infected women to promote continuity of care. METHODS: Women living with HIV and receiving care at hospitals in Oromia Region, Ethiopia and Zambezia Province, Mozambique were shown nine choice cards and asked to select one of two hypothetical health facilities, each with six varying characteristics related to the delivery of HIV services for long term treatment. Mixed logit models were used to estimate the influence of six health service attributes on choice of clinics. RESULTS: 2,033 women participated in the study (response rate 97.8% in Ethiopia and 94.7% in Mozambique). Among the various attributes of structure and content of lifelong ART services, the most important attributes identified in both countries were respectful provider attitude and ability to obtain non-HIV health services during HIV-related visits. Availability of counseling support services was also a driver of choice. Facility type, i.e., hospital versus health center, was substantially less important. CONCLUSIONS: Efforts to enhance retention in HIV care and treatment for pregnant women should focus on promoting respectful care by providers and integrating access to non-HIV health services in the same visit, as well as continuing to strengthen counseling. |
Point-of-care HIV testing at antenatal care and maternity sites: experience in Battambang Province, Cambodia
Heller T , Kunthea S , Bunthoeun E , Sok K , Seuth C , Killam WP , Sovanna T , Sathiarany V , Kanal K . Int J STD AIDS 2011 22 (12) 742-7 Worldwide elimination of HIV transmission from mother-to-child is theoretically achievable. In Cambodia, antenatal care (ANC) prevalence has dropped from 1.6% (2003) to 0.71% (2009). However, success in minimizing vertical transmission has been limited by low testing uptake at ANC and delivery. We trained midwives in counselling and performance of an HIV rapid test, incorporated point-of-care testing into routine antenatal and maternity services and determined acceptability, feasibility, accuracy, cost and yield after one year. In all, 97.3% of ANC clients and 73.0% of maternity admissions had unknown HIV status. Testing was offered to 97.6% and 95.0% of untested ANC and maternity clients, respectively. Acceptance rates were 95.5% and 99.4%. Partner testing rate was 38.6%. HIV was diagnosed in 0.1% of ANC clients, 0.4% of partners and 0.9% of women at delivery. For an operational district with an average population of 158,000, point-of-care testing was estimated in one year to identify 19 HIV-infected pregnant women, nine men, 14 discordant couples and 16 exposed infants who otherwise would have not received prophylaxis. Cost was less than $3.75 per person tested. Point-of-care testing during ANC and at delivery is feasible, acceptable and contributes to reducing mother-to-child transmission. |
Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification
Edupuganti S , Rouphael N , Mehta A , Eaton M , Heller JG , Bressler A , Brandt M , O'Donnell K . J Clin Microbiol 2011 49 (6) 2350-3 Fusarium is a ubiquitous mold that can cause superficial infections such as keratitis and onychomycosis in immunocompetent humans; however, infections in immunocompromised hosts can be fatal. We report an unusual case of epidural abscess and vertebral osteomyelitis in a patient with an autoimmune disorder who was on long term glucocorticoids. Multilocus DNA sequence-based typing revealed that the infection was caused by a novel three-locus haplotype of Fusarium falciforme designated FSSC 3+4qqq. |
- Page last reviewed:Feb 1, 2024
- Page last updated:Dec 02, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure